← COLLEGIUM PHARMACEUTICAL, INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $153.2m | $118.7m | $146.6m | $170.0m | $174.1m | $186.4m | $173.7m | $238.9m | $70.6m | $231.3m | |
| Prepaid Expense and Other Assets, Current | $1.9m | $3.0m | $5.1m | $3.1m | $4.8m | $5.9m | $16.7m | $15.2m | $30.4m | $32.6m | |
| Inventory, Net | $1.3m | $1.8m | $7.8m | $9.6m | $15.6m | $17.4m | $46.5m | $32.3m | $35.6m | $40.9m | |
| Assets, Current | $158.6m | $133.5m | $237.5m | $255.7m | $277.9m | $315.5m | $420.0m | $537.6m | $482.3m | $691.4m | |
| Property, Plant and Equipment, Net | $1.0m | $1.8m | $9.3m | $11.9m | $19.0m | $19.5m | $19.5m | $16.0m | $14.3m | $12.0m | |
| Goodwill | — | — | — | — | — | — | $133.7m | $133.9m | $162.3m | $145.9m | |
| Intangible Assets, Net (Excluding Goodwill) | — | — | — | — | — | — | $567.5m | $421.7m | $891.4m | $669.5m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $9.0m | $8.4m | $7.6m | $6.9m | $6.0m | $5.8m | $4.2m | |
| Other Assets, Noncurrent | $204k | $161k | $204k | $178k | $123k | $87k | $100k | $825k | $8.4m | $20.2m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | $2.1m | $10.0m | $77.9m | $73.0m | $83.3m | $105.8m | $183.1m | $179.5m | $228.5m | $211.3m | |
| Accrued Liabilities, Current | $8.9m | $8.5m | $30.6m | $33.5m | $24.7m | $29.2m | $36.1m | $37.6m | $72.1m | $62.5m | |
| Assets | $162.0m | $135.6m | $291.2m | $306.3m | $643.8m | $692.1m | $1.2b | $1.1b | $1.7b | $1.7b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $656k | $730k | $814k | $1.1m | $988k | $1.3m | $1.4m | |
| Accounts Payable, Current | $9.1m | $5.7m | $12.2m | $6.2m | $10.0m | $4.2m | $3.5m | $8.7m | $3.9m | $10.7m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $9.4m | $8.8m | $8.0m | $7.1m | $6.1m | $5.5m | $4.1m | |
| Liabilities, Current | $25.6m | $31.5m | $189.1m | $201.8m | $239.5m | $279.6m | $433.7m | $457.9m | $509.5m | $440.0m | |
| Deferred Income Tax Liabilities, Net | — | — | — | — | — | — | $94.5m | $71.2m | $54.2m | $29.1m | |
| Other Liabilities, Noncurrent | — | — | $676k | — | — | — | — | — | — | — | |
| Long-term Debt | $4.1m | — | $11.5m | $11.5m | — | — | — | — | — | — | |
| Liabilities | $27.1m | $31.5m | $199.7m | $218.9m | $457.8m | $489.1m | $979.3m | $947.9m | $1.4b | $1.4b | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | — | — | — | — | — | — | — | — | $0 | $0 | |
| Common Stock, Value, Issued | $29k | $33k | $33k | $34k | $35k | $36k | $37k | $38k | $40k | $41k | |
| Additional Paid in Capital | $358.1m | $402.1m | $428.7m | $447.3m | $519.1m | $502.1m | $538.1m | $565.9m | $590.3m | $625.0m | |
| Retained Earnings (Accumulated Deficit) | ($223.2m) | ($298.0m) | ($337.2m) | ($359.9m) | ($333.1m) | ($256.3m) | ($281.3m) | ($233.2m) | ($164.0m) | ($101.1m) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | — | — | — | — | — | — | — | $14k | $55k | $319k | |
| Stockholders' Equity Attributable to Parent | $134.9m | $104.1m | $91.6m | $87.4m | $186.0m | $202.9m | $194.8m | $195.4m | $228.8m | $301.7m | |
| Liabilities and Equity | $162.0m | $135.6m | $291.2m | $306.3m | $643.8m | $692.1m | $1.2b | $1.1b | $1.7b | $1.7b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.